Cost accounting in cost utility analysis of screening and treatment.
Vanagas
Giedrius
G
D000975:Antioxidants / Q000627:therapeutic use; D003362:Cost-Benefit Analysis / Q000379:methods*; D006801:Humans; D008268:Macular Degeneration / Q000175:diagnosis; D018803:Models, Economic; D015032:Zinc / Q000627:therapeutic use
D000975:Antioxidants; D015032:Zinc